PE20061137A1 - Compuestos derivados de macrolidos amino sustituidas - Google Patents

Compuestos derivados de macrolidos amino sustituidas

Info

Publication number
PE20061137A1
PE20061137A1 PE2005001311A PE2005001311A PE20061137A1 PE 20061137 A1 PE20061137 A1 PE 20061137A1 PE 2005001311 A PE2005001311 A PE 2005001311A PE 2005001311 A PE2005001311 A PE 2005001311A PE 20061137 A1 PE20061137 A1 PE 20061137A1
Authority
PE
Peru
Prior art keywords
morocco
quinolinyl
dihydro
oxo
carboxy
Prior art date
Application number
PE2005001311A
Other languages
English (en)
Spanish (es)
Inventor
Desmond John Best
Andrew Keith Forrest
Andrea Fajdetic
Robert John Sheppard
John Stephen Elder
Original Assignee
Glaxo Group Ltd
Pliva Istrazivacki Inst D O O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd, Pliva Istrazivacki Inst D O O filed Critical Glaxo Group Ltd
Publication of PE20061137A1 publication Critical patent/PE20061137A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PE2005001311A 2004-11-11 2005-11-09 Compuestos derivados de macrolidos amino sustituidas PE20061137A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0424959A GB0424959D0 (en) 2004-11-11 2004-11-11 Novel compounds

Publications (1)

Publication Number Publication Date
PE20061137A1 true PE20061137A1 (es) 2006-12-13

Family

ID=33523587

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2005001311A PE20061137A1 (es) 2004-11-11 2005-11-09 Compuestos derivados de macrolidos amino sustituidas

Country Status (19)

Country Link
US (2) US7718621B2 (enExample)
EP (1) EP1824870A1 (enExample)
JP (1) JP2008519788A (enExample)
KR (1) KR20070085919A (enExample)
CN (1) CN101098881A (enExample)
AR (1) AR053311A1 (enExample)
AU (1) AU2005303961A1 (enExample)
BR (1) BRPI0517792A (enExample)
CA (1) CA2587413A1 (enExample)
GB (1) GB0424959D0 (enExample)
IL (1) IL182978A0 (enExample)
MA (1) MA29213B1 (enExample)
MX (1) MX2007005776A (enExample)
NO (1) NO20072939L (enExample)
PE (1) PE20061137A1 (enExample)
RU (1) RU2007121581A (enExample)
TW (1) TW200630378A (enExample)
WO (1) WO2006050942A1 (enExample)
ZA (1) ZA200703603B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601695B2 (en) 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
WO2007054295A1 (en) * 2005-11-09 2007-05-18 Glaxo Group Limited New 4*-substituted erythromycin derivative
EP1879904A1 (en) * 2005-05-10 2008-01-23 GlaxoSmithKline istrazivacki centar Zagreb d.o.o. 4" amino linked macrolides useful for the treatment of microbial infections
WO2007054296A1 (en) * 2005-11-09 2007-05-18 Glaxo Group Limited Macrolones
NZ583878A (en) 2007-09-14 2012-10-26 Vertex Pharma Modulators of ABC transporter and cystic fibrosis transmembrane conductance regulator (CFTR)
AU2008316830B2 (en) 2007-10-25 2016-03-17 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
TW200946109A (en) * 2008-05-09 2009-11-16 Enanta Pharm Inc Anti-bacterial activity of 9-hydroxy derivatives 6, 11-bicyclolides
CN107854477A (zh) 2008-10-24 2018-03-30 森普拉制药公司 使用含三唑的大环内酯治疗抗性疾病的方法
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
US9480679B2 (en) 2009-09-10 2016-11-01 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
BR112012029586A2 (pt) * 2010-05-20 2016-08-02 Cempra Pharmaceuticals Inc processos para preparar macrolídeos e cetolídeos e intermediários dos mesmos
KR20130120458A (ko) 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
WO2013148891A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
WO2014152326A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
AU2014233240B2 (en) 2013-03-15 2018-08-09 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
CN106589023A (zh) * 2016-11-22 2017-04-26 宜昌东阳光药业股份有限公司 一种罗红霉素杂质及其合成方法
CN110475777B (zh) 2017-03-30 2022-04-15 豪夫迈·罗氏有限公司 用于治疗和预防细菌感染的新吡啶并[2,3-b]吲哚化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2808070A1 (de) * 1978-02-24 1979-08-30 Bayer Ag Verfahren zur herstellung von 4-pyridon-3-carbonsaeuren und/oder deren derivaten
GB0127349D0 (en) 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
GB0225384D0 (en) 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds

Also Published As

Publication number Publication date
US20080090773A1 (en) 2008-04-17
MX2007005776A (es) 2007-07-16
AR053311A1 (es) 2007-05-02
TW200630378A (en) 2006-09-01
EP1824870A1 (en) 2007-08-29
US20080269146A1 (en) 2008-10-30
NO20072939L (no) 2007-08-08
MA29213B1 (fr) 2008-02-01
KR20070085919A (ko) 2007-08-27
RU2007121581A (ru) 2008-12-20
US7718621B2 (en) 2010-05-18
CN101098881A (zh) 2008-01-02
GB0424959D0 (en) 2004-12-15
AU2005303961A1 (en) 2006-05-18
JP2008519788A (ja) 2008-06-12
IL182978A0 (en) 2007-08-19
CA2587413A1 (en) 2006-05-18
WO2006050942A1 (en) 2006-05-18
ZA200703603B (en) 2008-07-30
BRPI0517792A (pt) 2008-10-21

Similar Documents

Publication Publication Date Title
US8524738B2 (en) Quinolinones and quinoxalinones as antibacterial composition
NZ623574A (en) Ketolide compounds
MX2009005449A (es) Compuesto heteromonociclico y uso del mismo.
AR027117A1 (es) Trifluorometilpirrolcarboxamidas y trifluorometilpirroltioamidas como fungicidas
PL358225A1 (en) Novel phenyl-propargylether derivatives
PH12019502042A1 (en) Fungicidal composition and method for controlling plant diseases
JP2010511667A5 (enExample)
NZ594675A (en) Actagardine derivatives
CA2744756A1 (en) Monocarbams and their use as antibacterial agent
PE20140649A1 (es) Derivado de macrolido sustituido en la posicion c4
NZ596628A (en) Ketolide compounds having antimicrobial activity
UA101305C2 (ru) Антибактериальные производные хинолина
TW200630378A (en) Macrolones-amino substituted quinolones
MX2007005709A (es) Compuestos de n-sulfonilaminobencil-2-fenoxiacetamida sustituidos.
MY156304A (en) 5-hydroxymethyl-oxazolidin-2-one derivatives for treating bacterial intestinal diseases
MX2010002932A (es) Macrolidos de biarilo con puente en 6, 11.
RU2009125520A (ru) Антибактериальные хинолиновые производные
PE20050582A1 (es) Derivados de quinolona como agentes antibacterianos
JP2010511671A5 (enExample)
HRP20100384T1 (hr) Antibakterijski derivati kvinolina
MX2009009074A (es) Macrolidos basados en eritromicina.
JO2970B1 (en) Quinoline antibacterial derivatives
JP2010511670A5 (enExample)
UA101307C2 (ru) Антибактериальные производные хинолина
Foroumadi et al. Synthesis and in‐vitro antibacterial activity of new N‐substituted piperazinyl quinolones

Legal Events

Date Code Title Description
FC Refusal